Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer

Diffuse alveolar hemorrhage (DAH) is a serious pulmonary complication in patients with autoimmune diseases who are undergoing chemotherapy or have had hematopoietic stem cell transplantation. The use of recombinant factor VIIa (rFVIIa) to treat the acute phase of DAH by endobronchial bronchoscopy ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Esper, Raúl Carrillo, Estrada, Isis Espinoza de los Monteros, de la Torre León, Teresa, Gutiérrez, Agustín Omar Rosales, López, Jorge Arturo Nava
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336265/
https://www.ncbi.nlm.nih.gov/pubmed/25705408
http://dx.doi.org/10.1186/s40560-014-0047-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4336265/
https://www.ncbi.nlm.nih.gov/pubmed/25705408
http://dx.doi.org/10.1186/s40560-014-0047-2

Ejemplares similares